Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Nature Communications
|
November 23, 2025
Automated MRI system for clinically significant prostate cancer detection development validation and real-world implementation
Hanchang Wu, Fang Liu, Qingsong Yang, et al.
Journal of Clinical and Translational Hepatology
|
May 23, 2024
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients
Jinlin Hou, Qin Ning, Zhongping Duan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 14, 2022
Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug-induced liver injury: A multicenter, randomized, phase II trial
Jieting Tang, Jin Gu, Naihui Chu, et al.
Journal of Clinical and Translational Hepatology
|
March 11, 2026
Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China
Jinlin Hou, Qin Ning, Zhongping Duan, et al.
Hepatology International
|
April 13, 2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Xieer Liang, Zhiliang Gao, Qing Xie, et al.
Hepatology International
|
May 29, 2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial
Yu Wang, Huifen Wang, Jun Cheng, et al.
Medicine
|
November 29, 2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
Hong Ma, Minde Zeng, Ying Han, et al.
Hepatology (Baltimore, Md.)
|
January 3, 2014
The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study
Jian Sun, Qing Xie, Deming Tan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 24, 2017
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B
Rui Yu, Deming Tan, Qin Ning, et al.
Journal of Gastroenterology and Hepatology
|
October 30, 2014
Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients
Xieer Liang, Jun Cheng, Yongtao Sun, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Nature Communications
|
November 23, 2025
Automated MRI system for clinically significant prostate cancer detection development validation and real-world implementation
Hanchang Wu, Fang Liu, Qingsong Yang, et al.
Journal of Clinical and Translational Hepatology
|
May 23, 2024
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients
Jinlin Hou, Qin Ning, Zhongping Duan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 14, 2022
Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug-induced liver injury: A multicenter, randomized, phase II trial
Jieting Tang, Jin Gu, Naihui Chu, et al.
Journal of Clinical and Translational Hepatology
|
March 11, 2026
Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China
Jinlin Hou, Qin Ning, Zhongping Duan, et al.
Hepatology International
|
April 13, 2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Xieer Liang, Zhiliang Gao, Qing Xie, et al.
Hepatology International
|
May 29, 2026
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial
Yu Wang, Huifen Wang, Jun Cheng, et al.
Medicine
|
November 29, 2016
A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
Hong Ma, Minde Zeng, Ying Han, et al.
Hepatology (Baltimore, Md.)
|
January 3, 2014
The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study
Jian Sun, Qing Xie, Deming Tan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 24, 2017
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B
Rui Yu, Deming Tan, Qin Ning, et al.
Journal of Gastroenterology and Hepatology
|
October 30, 2014
Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients
Xieer Liang, Jun Cheng, Yongtao Sun, et al.
Page
of 9